Market Place
Sourcing Support
Menarini`s Tenkasi (Oritavancin) Receives Approval in Europe
08 Jun 2023 //
EMA
Melinta Announces Two Key Milestones for KIMYRSA
20 Sep 2021 //
BUSINESSWIRE
Melinta Therapeutics Announces Commercial Availability of KIMYRSA™ (oritavancin)
07 Jul 2021 //
BUSINESSWIRE
Melinta Therapeutics Announces FDA Approval of KIMYRSA™
15 Mar 2021 //
BUSINESSWIRE
Melinta won FDA approval for skin infection fighter Kimyrsa
15 Mar 2021 //
FIERCEPHARMA
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
Menarini Group announces a commercial agreement for Vabomere, Orbactiv & Minocin
11 Oct 2018 //
PR NEWSWIRE
Melinta Therapeutics Announces Closing of Underwritten Public Offering
29 May 2018 //
PRESS RELEASE
Melinta to Highlight Commitment to Antibiotics and Product Portfolio
08 Mar 2018 //
PRESS RELEASE
Melinta Completes Acquisition of The Medicines Company’s
08 Jan 2018 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.